Wednesday, July 2, 2025 7/2/2025

The Alliance NCTN Biorepository and Biospecimen Resource

Award Number: U24CA196171
ORGANIZATION: NATIONAL CANCER INSTITUTE
OPDIV: NIH
AWARD CLASS: COOPERATIVE AGREEMENT
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 05/19/2015
PERIOD OF PERFORMANCE END DATE: 03/31/2026

Group Awards By:

View Award Description

The Alliance NCTN Biorepository and Biospecimen Resource - PROJECT SUMMARY/ABSTRACT The NCTN's Alliance for Clinical Trials in Oncology (Alliance) and its associated biorepositories represent an unequaled resource of expertise, institutional infrastructure, and high quality, densely annotated patient biospecimens collected from several decades of cancer therapeutic trials. The scientific mission of the Alliance Biorepository and Biospecimen Resource (ABBR) is to support the activities of the Alliance, the NCTN, and the broader cancer research community through four specific aims, which are: 1) To prospectively support Alliance and NCTN-wide clinical cancer trials with respect to biospecimen procurement, tracking, processing, quality assurance, storage, and distribution. The ABBR implements a number of innovative approaches to streamline biospecimen collection and support the collection of novel biospecimen types for genomic, proteomic, immunoncology, and `liquid biopsy' biomarker studies in the context of therapeutic trials; 2) To provide a resource of high quality, densely annotated biospecimens for secondary correlative science studies directed toward biomarker validation with high clinical impact. The ABBR cooperates with other NCTN biorepositories, the NCTN Biospecimen `Front Door Service', and the NCTN Navigator tool to provide inventories of biospecimens that may be suitable for secondary correlative science studies proposed both within the NCTN groups as well as the broader cancer research community. It also works with other NCTN members and NCI to create an efficient and transparent process for reviewing, approving, and executing such requests so as to speed the translation of candidate biomarkers to cancer diagnostics with clinical utility; 3) To provide scientific leadership to the NCTN biobanking enterprise, by active participation in the NCTN Group Banking Committee (GBC). The ABBR will continue its outstanding commitment to harmonizing and improving biobanking Best Practices by active participation in GBC meetings, subcommittees activities, and work products, and; 4) To provide expertise and infrastructure support for biobanking efforts aligned with and beyond the NCTN, including the Cancer and Immune Monitoring Analysis Centers (CIMACs) and the Community Oncology Research Program (NCORP). Having created a federated infrastructure of biorepository sites and a unifying informatics platform for tracking biospecimens across them, the ABBR continues to be uniquely poised to collaborate with other NCI programs, whenever biorepository or biospecimen resources are required for specific translational cancer research efforts.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2025 ( Subtotal = $2,849,375 )
2025	2025	WASHINGTON UNIVERSITY, THE	1 BROOKINGS DR	SAINT LOUIS	MO	63130	SAINT LOUIS	USA	Cancer Detection and Diagnosis Research	001	11	5/23/2025	NON-COMPETING CONTINUATION	$2,849,375
2025	2024	WASHINGTON UNIVERSITY, THE	1 BROOKINGS DR	SAINT LOUIS	MO	63130	SAINT LOUIS	USA	Cancer Detection and Diagnosis Research	000	10	3/4/2025	NON-COMPETING CONTINUATION	$0
														Subtotal = $2,849,375

Issue Date FY: 2024 ( Subtotal = $1,167,765 )
2024	2024	WASHINGTON UNIVERSITY, THE	ONE BROOKINGS DR	SAINT LOUIS	MO	63110	SAINT LOUIS CITY	USA	Cancer Detection and Diagnosis Research	000	10	5/13/2024	NON-COMPETING CONTINUATION	$1,167,765
														Subtotal = $1,167,765

Issue Date FY: 2023 ( Subtotal = $3,958,268 )
2023	2023	WASHINGTON UNIVERSITY, THE	ONE BROOKINGS DR	SAINT LOUIS	MO	63130	SAINT LOUIS	USA	Cancer Detection and Diagnosis Research	002	9	9/15/2023	NON-COMPETING CONTINUATION	$245,730
2023	2023	WASHINGTON UNIVERSITY, THE	ONE BROOKINGS DR	SAINT LOUIS	MO	63130	SAINT LOUIS	USA	Cancer Detection and Diagnosis Research	001	9	5/22/2023	NON-COMPETING CONTINUATION	$3,712,538
2023	2022	WASHINGTON UNIVERSITY, THE	ONE BROOKINGS DR	SAINT LOUIS	MO	63130	SAINT LOUIS	USA	Cancer Detection and Diagnosis Research	000	8	1/19/2023	NON-COMPETING CONTINUATION	$0
														Subtotal = $3,958,268

Issue Date FY: 2022 ( Subtotal = $3,718,673 )
2022	2022	WASHINGTON UNIVERSITY, THE	ONE BROOKINGS DR	SAINT LOUIS	MO	63130	SAINT LOUIS	USA	Cancer Detection and Diagnosis Research	001	8	3/14/2022	NON-COMPETING CONTINUATION	$3,415,105
2022	2022	WASHINGTON UNIVERSITY, THE	ONE BROOKINGS DR	SAINT LOUIS	MO	63130	SAINT LOUIS	USA	Cancer Detection and Diagnosis Research	002	8	5/19/2022	NON-COMPETING CONTINUATION	$303,568
2022	2021	WASHINGTON UNIVERSITY, THE	ONE BROOKINGS DR	SAINT LOUIS	MO	63130	SAINT LOUIS	USA	Cancer Detection and Diagnosis Research	000	7	11/23/2021	NON-COMPETING CONTINUATION	$0
														Subtotal = $3,718,673

Issue Date FY: 2021 ( Subtotal = $3,308,251 )
2021	2021	WASHINGTON UNIVERSITY, THE	ONE BROOKINGS DR	SAINT LOUIS	MO	63130	SAINT LOUIS	USA	Cancer Detection and Diagnosis Research	003	7	3/30/2021	NON-COMPETING CONTINUATION	$3,308,251
2021	2020	WASHINGTON UNIVERSITY, THE	ONE BROOKINGS DR	SAINT LOUIS	MO	63130	SAINT LOUIS	USA	Cancer Detection and Diagnosis Research	001	6	1/25/2021	COMPETING CONTINUATION	$932,477
2021	2020	WASHINGTON UNIVERSITY, THE	ONE BROOKINGS DR	SAINT LOUIS	MO	63130	SAINT LOUIS	USA	Cancer Detection and Diagnosis Research	002	5	1/25/2021	SUPPLEMENT FOR EXPANSION	-$895,061
2021	2019	WASHINGTON UNIVERSITY, THE	ONE BROOKINGS DR	SAINT LOUIS	MO	63130	SAINT LOUIS	USA	Cancer Detection and Diagnosis Research	000	5	1/25/2021	NON-COMPETING CONTINUATION	-$37,416
														Subtotal = $3,308,251

Issue Date FY: 2020 ( Subtotal = $3,216,177 )
2020	2020	WASHINGTON UNIVERSITY, THE	ONE BROOKINGS DR	SAINT LOUIS	MO	63130	SAINT LOUIS	USA	Cancer Detection and Diagnosis Research	003	6	7/30/2020	COMPETING CONTINUATION	$696,085
2020	2020	WASHINGTON UNIVERSITY, THE	ONE BROOKINGS DR	SAINT LOUIS	MO	63130	SAINT LOUIS	USA	Cancer Detection and Diagnosis Research	002	5	5/28/2020	SUPPLEMENT FOR EXPANSION	$895,061
2020	2020	WASHINGTON UNIVERSITY, THE	ONE BROOKINGS DR	SAINT LOUIS	MO	63130	SAINT LOUIS	USA	Cancer Detection and Diagnosis Research	005	6	9/18/2020	COMPETING CONTINUATION	$416,721
2020	2020	WASHINGTON UNIVERSITY, THE	ONE BROOKINGS DR	SAINT LOUIS	MO	63130	SAINT LOUIS	USA	Cancer Detection and Diagnosis Research	004	6	8/20/2020	COMPETING CONTINUATION	$1,208,310
2020	2019	WASHINGTON UNIVERSITY, THE	ONE BROOKINGS DR	SAINT LOUIS	MO	63130	SAINT LOUIS	USA	Cancer Detection and Diagnosis Research	001	5	5/28/2020	NON-COMPETING CONTINUATION	$0
2020	2019	WASHINGTON UNIVERSITY, THE	ONE BROOKINGS DR	SAINT LOUIS	MO	63130	SAINT LOUIS	USA	Cancer Detection and Diagnosis Research	000	5	12/9/2019	NON-COMPETING CONTINUATION	$0
														Subtotal = $3,216,177

Issue Date FY: 2019 ( Subtotal = $2,706,967 )
2019	2019	WASHINGTON UNIVERSITY, THE	ONE BROOKINGS DR	SAINT LOUIS	MO	63130	SAINT LOUIS	USA	Cancer Detection and Diagnosis Research	002	5	9/9/2019	NON-COMPETING CONTINUATION	$546,321
2019	2019	WASHINGTON UNIVERSITY, THE	ONE BROOKINGS DR	SAINT LOUIS	MO	63130	SAINT LOUIS	USA	Cancer Detection and Diagnosis Research	001	5	3/27/2019	NON-COMPETING CONTINUATION	$2,160,646
2019	2018	WASHINGTON UNIVERSITY, THE	ONE BROOKINGS DR	SAINT LOUIS	MO	63130	SAINT LOUIS	USA	Cancer Detection and Diagnosis Research	000	4	11/5/2018	NON-COMPETING CONTINUATION	$0
														Subtotal = $2,706,967

Issue Date FY: 2018 ( Subtotal = $2,718,695 )
2018	2018	WASHINGTON UNIVERSITY, THE	ONE BROOKINGS DR	SAINT LOUIS	MO	63130	SAINT LOUIS	USA	Cancer Detection and Diagnosis Research	000	4	3/20/2018	NON-COMPETING CONTINUATION	$1,896,410
2018	2018	WASHINGTON UNIVERSITY, THE	ONE BROOKINGS DR	SAINT LOUIS	MO	63130	SAINT LOUIS	USA	Cancer Detection and Diagnosis Research	002	4	9/11/2018	SUPPLEMENT FOR EXPANSION	$599,536
2018	2018	WASHINGTON UNIVERSITY, THE	ONE BROOKINGS DR	SAINT LOUIS	MO	63130	SAINT LOUIS	USA	Cancer Detection and Diagnosis Research	001	4	5/25/2018	NON-COMPETING CONTINUATION	$222,749
														Subtotal = $2,718,695

Issue Date FY: 2017 ( Subtotal = $2,029,001 )
2017	2017	WASHINGTON UNIVERSITY, THE	ONE BROOKINGS DR	SAINT LOUIS	MO	63130	SAINT LOUIS	USA	Cancer Detection and Diagnosis Research	001	3	6/9/2017	NON-COMPETING CONTINUATION	$223,517
2017	2017	WASHINGTON UNIVERSITY, THE	ONE BROOKINGS DR	SAINT LOUIS	MO	63130	SAINT LOUIS	USA	Cancer Detection and Diagnosis Research	000	3	5/8/2017	NON-COMPETING CONTINUATION	$1,805,484
														Subtotal = $2,029,001

Issue Date FY: 2016 ( Subtotal = $2,228,496 )
2016	2016	WASHINGTON UNIVERSITY	CAMPUS BOX 1034	SAINT LOUIS	MO	63112	SAINT LOUIS CITY	USA	Cancer Detection and Diagnosis Research	001	2	9/16/2016	NON-COMPETING CONTINUATION	$1,706,726
2016	2016	WASHINGTON UNIVERSITY	CAMPUS BOX 1034	SAINT LOUIS	MO	63112	SAINT LOUIS CITY	USA	Cancer Detection and Diagnosis Research	002	2	9/19/2016	NON-COMPETING CONTINUATION	-$1,706,726
2016	2016	WASHINGTON UNIVERSITY	CAMPUS BOX 1034	SAINT LOUIS	MO	63112	SAINT LOUIS CITY	USA	Cancer Detection and Diagnosis Research	000	2	4/5/2016	NON-COMPETING CONTINUATION	$2,228,496
														Subtotal = $2,228,496

Issue Date FY: 2015 ( Subtotal = $3,327,369 )
2015	2015	WASHINGTON UNIVERSITY	CAMPUS BOX 1034	SAINT LOUIS	MO	63112	SAINT LOUIS CITY	USA	Cancer Detection and Diagnosis Research	001	1	8/12/2015	NEW	$680,829
2015	2015	WASHINGTON UNIVERSITY	CAMPUS BOX 1034	SAINT LOUIS	MO	63112	SAINT LOUIS CITY	USA	Cancer Detection and Diagnosis Research	000	1	5/19/2015	NEW	$2,280,654
2015	2015	WASHINGTON UNIVERSITY	CAMPUS BOX 1034	SAINT LOUIS	MO	63112	SAINT LOUIS CITY	USA	Cancer Detection and Diagnosis Research	002	1	8/21/2015	NEW	$365,886
														Subtotal = $3,327,369

Grand Total All Awards = $31,229,037

Top

All Categories

About

Search

Reports

Data Submission

Award Information

The Alliance NCTN Biorepository and Biospecimen Resource

Award Number: U24CA196171

ORGANIZATION: NATIONAL CANCER INSTITUTE

OPDIV: NIH

AWARD CLASS: COOPERATIVE AGREEMENT

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 05/19/2015

PERIOD OF PERFORMANCE END DATE: 03/31/2026

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer